Genetic Analysis AS (XSAT:GEAN) Inventories, Raw Materials & Components: kr0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:GEAN Genetic Analysis AS XSAT:GEAN
34 GF Score
Price kr0.66
GF Value kr0.54
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Genetic Analysis AS Inventories, Raw Materials & Components?

Genetic Analysis AS XSAT:GEAN -2.94% 34 Inventories, Raw Materials & Components is kr0.00 Mil as of Mar. 2026. GuruFocus rates XSAT:GEAN with a GF Score™ of 34/100 and a GF Value™ of kr0.54 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Genetic Analysis AS's inventories, raw materials & components for the quarter that ended in Mar. 2026 was kr0.00 Mil.

Genetic Analysis AS's quarterly raw materials increased from Sep. 2025 (kr0.00 Mil) to Dec. 2025 (kr0.76 Mil) but then declined from Dec. 2025 (kr0.76 Mil) to Mar. 2026 (kr0.00 Mil).

Genetic Analysis AS's annual raw materials declined from Dec. 2023 (kr1.24 Mil) to Dec. 2024 (kr0.53 Mil) but then increased from Dec. 2024 (kr0.53 Mil) to Dec. 2025 (kr0.76 Mil).

Genetic Analysis AS Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Genetic Analysis AS's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Analysis AS Inventories, Raw Materials & Components Chart

Genetic Analysis AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 1.80 0.75 1.24 0.53 0.76

Genetic Analysis AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.76 0.00
XSAT:GEAN
34GF Score
Genetic Analysis AS XSAT:GEAN
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genetic Analysis AS Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of kr0.00 Mil mean?
Genetic Analysis AS (XSAT:GEAN) has a Inventories, Raw Materials & Components of kr0.00 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Genetic Analysis AS and its competitors.
Is Genetic Analysis AS's Inventories, Raw Materials & Components too high?
Genetic Analysis AS's current Inventories, Raw Materials & Components is kr0.00 Mil. Overall, Genetic Analysis AS has a GF Score™ of 34/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Genetic Analysis AS's Inventories, Raw Materials & Components compare to TMO and DHR?
Genetic Analysis AS's Inventories, Raw Materials & Components of kr0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Diagnostics & Research company?
A good Inventories, Raw Materials & Components depends on the Medical Diagnostics & Research industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Genetic Analysis AS and its competitors. Genetic Analysis AS's current Inventories, Raw Materials & Components is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Analysis AS stock overvalued right now?
Based on GuruFocus' analysis, Genetic Analysis AS (XSAT:GEAN) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.54, compared to a current price of kr0.66 — trading 22.2% above its estimated fair value. The current Inventories, Raw Materials & Components is kr0.00 Mil. Genetic Analysis AS's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Genetic Analysis AS (XSAT:GEAN), the current Inventories, Raw Materials & Components is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genetic Analysis AS (XSAT:GEAN) Overvalued in 2026?

Based on GuruFocus' analysis, Genetic Analysis AS stock appears to be overvalued. The current stock price of kr0.66 is trading 22.2% above its estimated GF Value™ of kr0.54. GuruFocus considers Genetic Analysis AS to be Modestly Overvalued.

Key valuation signals for XSAT:GEAN:

  • Inventories, Raw Materials & Components: kr0.00 Mil
  • GF Value™: kr0.54 vs. price of kr0.66 (22.2% above fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the XSAT:GEAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genetic Analysis AS Business Description

Other Exchanges 8V8:Germany
Address Ulvenveien 80, Oslo, NOR, 0581
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients. Geographically, it operates in the USA, Europe, and the Rest of the world. Geographically, the company sells products in the USA, Europe, and the rest of the world. The majority of its revenue is generated from the USA. The GA-map technology platform and product portfolio are currently used across three main market segments: Clinical diagnostics, research (academic and industry), and Consumer Health.
34GF Score

Get the complete analysis for XSAT:GEAN

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.66
Price
kr0.54
GF Value